Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Processes for quality improvements in radiation oncology clinical trials.

FitzGerald TJ, Urie M, Ulin K, Laurie F, Yorty J, Hanusik R, Kessel S, Jodoin MB, Osagie G, Cicchetti MG, Pieters R, McCarten K, Rosen N.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S76-9. doi: 10.1016/j.ijrobp.2007.07.2387.

2.

What we have learned: the impact of quality from a clinical trials perspective.

FitzGerald TJ.

Semin Radiat Oncol. 2012 Jan;22(1):18-28. doi: 10.1016/j.semradonc.2011.09.004. Review.

3.

Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.

Middleton M, Frantzis J, Healy B, Jones M, Murry R, Kron T, Plank A, Catton C, Martin J.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1576-81. doi: 10.1016/j.ijrobp.2010.09.017. Epub 2010 Nov 11.

PMID:
21074334
4.

Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.

Cui Y, Galvin JM, Parker W, Breen S, Yin FF, Cai J, Papiez LS, Li XA, Bednarz G, Chen W, Xiao Y.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):271-7. doi: 10.1016/j.ijrobp.2012.03.002. Epub 2012 Apr 27.

PMID:
22541964
6.

Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials.

Ibbott GS, Followill DS, Molineu HA, Lowenstein JR, Alvarez PE, Roll JE.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S71-5. doi: 10.1016/j.ijrobp.2007.08.083.

7.

Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing.

Taylor PA, Kry SF, Alvarez P, Keith T, Lujano C, Hernandez N, Followill DS.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):242-8. doi: 10.1016/j.ijrobp.2016.01.061. Epub 2016 Feb 10.

8.

Re: Multicentre quality assurance of intensity-modulated radiation therapy planning: beware the benchmarker.

Williams MJ, Bailey MJ, Forstner D, Metcalfe PE.

J Med Imaging Radiat Oncol. 2008 Jun;52(3):303. doi: 10.1111/j.1440-1673.2008.01960.x. No abstract available.

PMID:
18477127
9.

Impact of quality assurance rounds in a Canadian radiation therapy department.

Lefresne S, Olivotto IA, Joe H, Blood PA, Olson RA.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e117-21. doi: 10.1016/j.ijrobp.2012.10.015. Epub 2012 Nov 27.

PMID:
23195781
10.

Developing quality assurance processes for image-guided adaptive radiation therapy.

Yan D.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S28-32. doi: 10.1016/j.ijrobp.2007.08.082.

PMID:
18406933
11.

Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).

Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfart K, Lukas P, Plütschow A, Schmidberger H, Staar S, Fuchs M, Engert A, Eich HT.

Strahlenther Onkol. 2017 Feb;193(2):109-115. doi: 10.1007/s00066-016-1036-2. Epub 2016 Sep 5.

PMID:
27596217
12.

Quality assurance in radiation oncology.

Hulick PR, Ascoli FA.

J Am Coll Radiol. 2005 Jul;2(7):613-6.

PMID:
17411887
13.

Quality assurance issues in conducting multi-institutional advanced technology clinical trials.

Purdy JA.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S66-70. doi: 10.1016/j.ijrobp.2007.07.2393.

PMID:
18406941
14.

Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection.

Mackenzie J, Graham G, Olivotto IA.

Clin Oncol (R Coll Radiol). 2016 Dec;28(12):e192-e198. doi: 10.1016/j.clon.2016.08.012. Epub 2016 Sep 12.

PMID:
27633327
15.

Real-time pretreatment review limits unacceptable deviations on a cooperative group radiation therapy technique trial: quality assurance results of RTOG 0933.

Gondi V, Cui Y, Mehta MP, Manfredi D, Xiao Y, Galvin JM, Rowley H, Tome WA.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):564-70. doi: 10.1016/j.ijrobp.2014.10.054. Epub 2015 Jan 10.

16.

New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfarth K, Lukas P, Schmidberger H, Marnitz-Schulze S, Fuchs M, Engert A, Eich HT.

Strahlenther Onkol. 2017 Feb;193(2):100-108. doi: 10.1007/s00066-016-1048-y. Epub 2016 Sep 27.

PMID:
27678010
17.

Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program.

Rouette J, Gutierrez E, O'Donnell J, Reddeman L, Hart M, Foxcroft S, Mitera G, Warde P, Brundage MD; Cancer Care Ontario Radiation Oncology Program Leads; Pan-Canadian Peer Review Steering Committee.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):521-529. doi: 10.1016/j.ijrobp.2016.10.017. Epub 2016 Oct 20.

PMID:
28258891
18.

New technologies in radiation therapy: ensuring patient safety, radiation safety and regulatory issues in radiation oncology.

Amols HI.

Health Phys. 2008 Nov;95(5):658-65. doi: 10.1097/01.HP.0000326334.64242.46.

PMID:
18849700
19.

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).

Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB Jr, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):315-6. doi: 10.1016/j.ijrobp.2009.12.051. No abstract available.

20.

Current brachytherapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies?

Williamson JF.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S18-22. doi: 10.1016/j.ijrobp.2007.07.2388.

PMID:
18406923

Supplemental Content

Support Center